PRELUDE THERAPEUTICS INC Shares Outstanding (Cover Page)
PRELUDE THERAPEUTICS INC (PRLD) had Shares Outstanding (Cover Page) of 79.80 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 79.80M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 79.65M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 63.00M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 62.87M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 79.80M shares 10-Q · filed 2026-08-11 |
| 2026-05-07 | 79.65M shares 10-Q · filed 2026-05-12 |
| 2026-03-06 | 63.00M shares 10-K · filed 2026-03-10 |
| 2025-11-10 | 62.87M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 56.60M shares 10-Q · filed 2025-08-14 |
| 2025-04-30 | 56.46M shares 10-Q · filed 2025-05-06 |
| 2025-03-06 | 55.15M shares 10-K · filed 2025-03-10 |
| 2024-11-04 | 55.04M shares 10-Q · filed 2024-11-06 |
| 2024-08-07 | 55.02M shares 10-Q · filed 2024-08-12 |
| 2024-05-01 | 54.93M shares 10-Q · filed 2024-05-07 |
| 2024-02-09 | 54.92M shares 10-K · filed 2024-02-15 |
| 2023-10-27 | 54.83M shares 10-Q · filed 2023-11-01 |
| 2023-08-01 | 54.81M shares 10-Q · filed 2023-08-03 |
| 2023-05-01 | 47.96M shares 10-Q · filed 2023-05-08 |
| 2023-03-09 | 47.91M shares 10-K · filed 2023-03-15 |
| 2022-11-08 | 47.86M shares 10-Q · filed 2022-11-14 |
| 2022-08-02 | 47.83M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 47.70M shares 10-Q · filed 2022-05-10 |
| 2022-03-11 | 47.63M shares 10-K · filed 2022-03-17 |
| 2021-11-08 | 47.22M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 47.09M shares 10-Q · filed 2021-08-12 |
| 2021-05-07 | 46.96M shares 10-Q · filed 2021-05-11 |
| 2021-03-12 | 46.59M shares 10-K · filed 2021-03-16 |
| 2020-11-10 | 43.70M shares 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |